Fig. 2
From: New paradigm for stage III melanoma: from surgery to adjuvant treatment
Overall survival in association with different sizes of sentinel lymph node according to Van Akkoi et al. [20]. In their study, conducted in 388 patients at three major centers within the European Organization of Research and Treatment of Cancer (EORTC) Melanoma Group, estimated overall survival at 5 years was 91% for metastasis < 0.1 mm, 61% for 0.1–1.0 mm, and 51% for > 1.0 mm (p < 0.001)